PHGE BiomX Inc.

Develops drugs for cancer treatment

$0.73  +0.04 (6.34%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/28/2019
Outstanding shares:  29,780,409
Average volume:  32,366
Market cap:   $21,924,337
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.43
PS ratio:   0.00
Return on equity:   111.30%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy